Navigation

Gastrointestinal stromal tumours - sunitinib

Sunitinib for the treatment of gastrointestinal stromal tumours

Status: History
Expected date of issue: September 2009
Referral date: July 2008
Process: STA
Topic area:
  • Cancer
  • Digestive system
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Rebecca Trowman / Fay McCracken
Communications manager: Sarita Tamber
Project manager: Laura Malone
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 31 October 2008
1st appraisal committee meeting: 11 February 2009
2nd appraisal committee meeting 08 April 2009
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Pfizer (sunitinib)

 

Patient / Carer Groups

  • Rarer Cancers Forum
  • Sarcoma UK

 

Professional Groups

  • Association of Upper GI Surgeons
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians, Medical Oncology Joint Special Committee
  • Royal College of Radiologists

 

Others

  • Department of Health
  • Plymouth Teaching PCT
  • Welsh Assembly Government

General

  • Department of Health, Social Services and Public Safety for Northern Ireland
  • NHS Quality Improvement Scotland

 

ComparatorManufacturers

  • None

 

Evidence Review Group

  • Peninsula Technology Assessment Group, University of Exeter (PenTAG)
  • National Institute for Health Research (NIHR) Health Technology Assessment Programme (HTA Programme)

 

Associated Guideline Groups

  • National Collaborating Centre for Cancer

 

Associated Public Health Groups

  • None

 

Relevant research Groups

  • None

Top


 

Project history

Date Update
22 July 2009

The Final Appraisal Determination for this technology appraisal has been returned to the Appraisal Committee for reconsideration due to comments received on the FAD.

The comments referred to a point regarding the restrictions on performance status of patients with gastrointestinal stromal tumours included in the final recommendations that hadn’t been addressed by the Appraisal Committee in the way described by the commentators. The FAD was reviewed by the Committee on 15th July 2009

Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.